Crawford Professional Drugs, Inc. v. CVS Caremark Corp.

748 F.3d 241
CourtCourt of Appeals for the Fifth Circuit
DecidedApril 4, 2014
Docket12-60922
StatusPublished

This text of 748 F.3d 241 (Crawford Professional Drugs, Inc. v. CVS Caremark Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Crawford Professional Drugs, Inc. v. CVS Caremark Corp., 748 F.3d 241 (5th Cir. 2014).

Opinion

JAMES L. DENNIS, Circuit Judge:

The principal issue in this appeal is whether the district court erred in ordering the plaintiffs to submit their claims to arbitration. The Plaintiffs, entities that operate twenty-three locally owned drug stores in Mississippi, brought suit in Mississippi state court against the Defendants seeking damages and declarative and in-junctive relief. The four Defendants, (1) Caremark, L.L.C. (“Caremark”), (2) CVS Caremark Corporation (“CVS Caremark”), (3) CVS Pharmacy, Inc. (“CVS Pharmacy”), and (4) Caremark Rx, L.L.C. (“Care-mark Rx”), own and operate the second-largest chain of pharmacies and the largest pharmacy-benefit-management (“PBM”) network 1 in the United States. In their suit, the Plaintiffs assert two claims: first, that the Defendants committed common-law trade-secret misappropriation and intentional interference with business relations by unlawfully taking patient and prescription information confidentially disclosed by the Plaintiffs and by using that data to persuade patients and consumers to have prescriptions filled by pharmacies owned and operated by the Defendants, rather than by the Plaintiffs’ drug stores; and, second, that the Defendants, by excluding the Plaintiffs from certain Defendant-administered PBM networks have violated Mississippi’s Any Willing Provider Law, which protects a patient’s right to use any pharmacy of his choosing.

It is undisputed that two Plaintiffs entered into an agreement with Caremark (“the Provider Agreement”), which incorporates by reference another document (“the Provider Manual”), which contains an arbitration clause. It is also undisputed that all other Plaintiffs entered into a Provider Agreement, which incorporates by reference the Provider Manual, with Care-markPCS, which is not one of the four Defendants named in this suit. The remaining three Defendants — CVS Care-mark, CVS Pharmacy, and Caremark Rx (“the non-signatory Defendants”) — are non-signatories to any iteration of the Provider Agreement. After removing the Plaintiffs’ suit to federal court, all four Defendants moved to compel the Plaintiffs to arbitrate their claims pursuant to the arbitration contracts to which all or most the Defendants were not signatories under the Federal Arbitration Act (“FAA”), see 9 U.S.C. §§ 3-4. The Plaintiffs opposed the motion to compel arbitration, arguing that: (1) they may not be compelled to arbitrate their claims against the non-signatory Defendants because they had never entered into an agreement to arbitrate with those entities; (2) their claims are not subject to the Provider Agreement’s arbitration clause; and (3) the Provider Agreement *255 and the Provider Manual’s arbitration clause are procedurally and substantively unconscionable under Mississippi law. The district court rejected the Plaintiffs’ arguments and ordered them to submit their claims against all four Defendants to arbitration.

In Arthur Andersen LLP v. Carlisle, 556 U.S. 624, 129 S.Ct. 1896, 173 L.Ed.2d 832 (2009), the Supreme Court held that, under the FAA, traditional principles of state law may allow an arbitration contract to be enforced by or against non-parties to the contract through a number of state-contract-law theories, including equitable estoppel. The relevant Arizona law, made controlling by the Provider Agreement’s choice-of-law clause, supports the non-signatory Defendants’ motion to enforce the agreement to arbitrate against the Plaintiffs based on state-law equitable estoppel doctrine. Accordingly we AFFIRM the district court’s judgment compelling arbitration. Coincidentally, we recognize that our prior decisions applying federal common law, rather than state contract law, to decide such questions, see Grigson v. Creative Artists Agency L.L.C., 210 F.3d 524 (5th Cir.2000), have been modified to conform with Arthur Andersen.

BACKGROUND

The Defendants were formed in 2007 when CVS, a national pharmacy chain, merged with Caremark, the PBM. Insurance carriers frequently hire PBMs to administer the payment of claims for prescription drugs. Accordingly, following the merger, the Defendants operated retail pharmacies that were direct competitors to those owned and operated by the Plaintiffs. At the same time, the Defendants became responsible for administering insurance claims for prescription drug benefits. Each Plaintiff provides services in at least one of the PBM networks operated by the Defendants. They receive access to participants in those networks in exchange for agreeing to fill prescriptions at discounted prices.

The Plaintiffs brought suit against the Defendants in Mississippi state court. The Plaintiffs assert that the Defendants conspired in various ways to harm the Plaintiffs’ business interests. In particular, the Plaintiffs allege that the Defendants collected proprietary patient information from local pharmacies that participate in their PBM networks and used that information for the financial benefit of CVS pharmacies. The Plaintiffs further allege that the Defendants accepted payments from drug companies to directly market certain drugs to patients who are likely candidates based on their prescription history and that the Defendants directly targeted patients who filled subscriptions at non-CVS pharmacies for marketing of CVS pharmacies and services. Lastly, the Plaintiffs assert that the Defendants conspired to deprive patients of their right to use any pharmacy of their choosing by forming pharmacy networks that either exclude non-CVS pharmacies or provide economic incentives for using CVS pharmacies. See Miss.Code AnN. § 83-9-6. 2 The Plaintiffs allege that the *256 Defendants coerced prescription-drug benefit plans into requiring that all routine maintenance prescriptions be filled at CVS pharmacies. The Plaintiffs argued that these actions deprived them of millions of dollars in potential business and that the Defendants’ actions violated Mississippi’s Uniform Trade Secrets Act and Any Willing Provider Law. Additionally, the Plaintiffs claimed intentional interference with business relations and requested damages and in-junctive relief.

The Defendants removed the action to the U.S. District Court for the Southern District of Mississippi and moved to compel the Plaintiffs to arbitrate their claims against all four Defendants (or, in the alternative, to stay the federal proceeding until arbitration was completed) on the basis of the Provider Agreement and the Provider Manual’s arbitration clause. The district court found — and the Plaintiffs have not disputed — that each Plaintiff is a party to a Provider Agreement that incorporates the terms of the Provider Manual, which in turn includes an arbitration clause. That clause provides:

Any and all disputes in connection with or arising out of the Provider Agreement by the parties will be exclusively settled by arbitration before a single arbitrator in accordance with the Rules of the American Arbitration Association. The arbitrator must follow the rule of Law, and may only award remedies provided for in the Provider Agreement. ...

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ragone v. Atlantic Video at the Manhattan Center
595 F.3d 115 (Second Circuit, 2010)
Cargill Inc. v. Golden Chariot MV
31 F.3d 316 (Fifth Circuit, 1994)
Grigson v. Creative Artists Agency, L.L.C.
210 F.3d 524 (Fifth Circuit, 2000)
Bridas S.A.P.I.C. v. Government of Turkmenistan
345 F.3d 347 (Fifth Circuit, 2003)
Freudensprung v. Offshore Technical Services, Inc.
379 F.3d 327 (Fifth Circuit, 2004)
JP Morgan Chase & Co. v. Conegie Ex Rel. Lee
492 F.3d 596 (Fifth Circuit, 2007)
Perry v. Thomas
482 U.S. 483 (Supreme Court, 1987)
Gilmer v. Interstate/Johnson Lane Corp.
500 U.S. 20 (Supreme Court, 1991)
First Options of Chicago, Inc. v. Kaplan
514 U.S. 938 (Supreme Court, 1995)
Green Tree Financial Corp.-Alabama v. Randolph
531 U.S. 79 (Supreme Court, 2000)
Arthur Andersen LLP v. Carlisle
556 U.S. 624 (Supreme Court, 2009)
Amerisure Insurance v. Navigators Insurance
611 F.3d 299 (Fifth Circuit, 2010)
Noble Drilling Services, Inc. v. Certex USA, Inc.
620 F.3d 469 (Fifth Circuit, 2010)
Celanese Corp. v. Martin K. Eby Const. Co., Inc.
620 F.3d 529 (Fifth Circuit, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
748 F.3d 241, Counsel Stack Legal Research, https://law.counselstack.com/opinion/crawford-professional-drugs-inc-v-cvs-caremark-corp-ca5-2014.